OpenAI's CEO of AGI Deployment Fidji Simo Takes Medical Leave Amid Major Executive Reorganization
Key Takeaways
- ▸Fidji Simo, CEO of AGI Deployment, takes medical leave due to neuroimmune condition relapse after prioritizing work over health treatment
- ▸Greg Brockman assumes oversight of product teams during Simo's absence, while Brad Lightcap shifts to special projects role
- ▸Kate Rouch (CMO) also takes health-related leave and will return to a reduced role; OpenAI searches for new CMO and Chief Communications Officer
Summary
OpenAI announced a significant executive reorganization on Friday, with CEO of AGI Deployment Fidji Simo taking medical leave to focus on her health after a relapse of a neuroimmune condition. Simo, who joined OpenAI in August 2025 to oversee consumer-facing products including ChatGPT and Sora, disclosed that she has postponed medical tests and therapies since starting the role and needs to pursue new interventions to stabilize her condition. She is expected to take several weeks of leave.
During Simo's absence, President Greg Brockman will oversee product teams. Additionally, Chief Operating Officer Brad Lightcap is transitioning to a "special projects" role managing forward-deployed engineers, and Chief Marketing Officer Kate Rouch is taking a leave of absence for health reasons, with plans to return in a more narrowly scoped position. OpenAI is searching for replacements for both the CMO and Chief Communications Officer positions.
The reorganization occurs as OpenAI prepares for a potential IPO this year, following its record $122 billion funding round that valued the company at $852 billion. An OpenAI spokesperson stated the company remains "well-positioned to keep executing with continuity and momentum" despite the leadership changes.
- Reorganization occurs amid IPO preparations and follows Simo's recent decision to shutter the Sora app and refocus on core products
